BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 6894713)

  • 1. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
    Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
    Wilson WR; Whitmore GF; Hill RP
    Cancer Res; 1981 Jul; 41(7):2817-22. PubMed ID: 7018670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
    Robbie MA; Baguley BC; Denny WA; Gavin JB; Wilson WR
    Cancer Res; 1988 Jan; 48(2):310-9. PubMed ID: 2825971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells.
    Wilson WR; Harris NM; Ferguson LR
    Cancer Res; 1984 Oct; 44(10):4420-31. PubMed ID: 6547875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M; Andersson BS; McCredie KB; Beran M
    Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
    Jensen CG; Wilson WR; Bleumink AR
    Cancer Res; 1985 Feb; 45(2):717-25. PubMed ID: 3838148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
    Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
    Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM; Schneider RJ; Young CW
    Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR; Whitmore GF
    Radiat Res; 1981 Jul; 87(1):121-36. PubMed ID: 7019954
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
    Adams EG; Crampton SL; Bhuyan BK
    Cancer Res; 1981 Dec; 41(12 Pt 1):4981-7. PubMed ID: 6458356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal activity and kinetic response of cultured human cells to 4'-(9-acridinylamino)methanesulfon-m-anisidine.
    Drewinko B; Yang LY; Barlogie B
    Cancer Res; 1982 Jan; 42(1):107-11. PubMed ID: 6895609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y; Schwartz RE; Zwelling LA; Kerrigan D; Mattern MR; Charcosset JY; Jacquemin-Sablon A; Kohn KW
    Cancer Res; 1986 Feb; 46(2):611-6. PubMed ID: 3000581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
    Ahmann FR; Meyskens FL; Moon TE; Durie BG; Salmon SE
    Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation dependence of topoisomerase II mediated drug action.
    Sullivan DM; Glisson BS; Hodges PK; Smallwood-Kentro S; Ross WE
    Biochemistry; 1986 Apr; 25(8):2248-56. PubMed ID: 3011082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of arabinofuranosyladenine on radiation-induced chromosome damage in plateau-phase CHO cells measured by premature chromosome condensation: implications for repair and fixation of alpha-PLD.
    Iliakis G; Pantelias GE; Seaner R
    Radiat Res; 1988 May; 114(2):361-78. PubMed ID: 3375431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of DNA-protein cross-links induced by 4'-(9-acridinylamino)-methanesulfon-m-anisidide and by gamma-radiation.
    Chiu SM; Xue LY; Friedman LR; Oleinick NL
    Cancer Res; 1989 Feb; 49(4):910-4. PubMed ID: 2912561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC; Zwelling LA; Gormley P; Young RC
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
    Pommier Y; Zwelling LA; Kao-Shan CS; Whang-Peng J; Bradley MO
    Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
    Beran M; Andersson BS
    Cancer Res; 1987 Apr; 47(7):1897-904. PubMed ID: 3469023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.